Lv4
570 积分 2024-01-12 加入
Discovery of precision targeting EZH2 degraders for triple-negative breast cancer
4天前
已完结
Dual target PARP1/EZH2 inhibitors inducing excessive autophagy and producing synthetic lethality for triple-negative breast cancer therapy
5天前
已完结
The Potential Capacities of FTY720: Novel Therapeutic Functions, Targets, and Mechanisms against Diseases
8天前
已完结
Novel one-/two-photon excited carbazole/quinolinium photosensitizers manifest nanomolar and hypoxia-resistant tumor photodynamic therapy by accelerating apoptosis, ferroptosis, and autophagy
8天前
已完结
STING Inhibitors and Degraders: Potential Therapeutic Agents in Inflammatory Diseases
8天前
已完结
Emerging role of EZH2 in solid tumor metastasis
11天前
已完结
Multifunctional Biomimetic Liposomes with Improved Tumor‐Targeting for TNBC Treatment by Combination of Chemotherapy, Anti‐Angiogenesis and Immunotherapy
11天前
已完结
Mesoporous polydopamine Targeting CDK4/6 Inhibitor toward Brilliant Synergistic Immunotherapy of Breast Cancer
18天前
已完结
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer
24天前
已完结
Sciatic nerve stimulation enhances NK cell cytotoxicity through dopamine signaling and synergizes immunotherapy in triple-negative breast cancer
1个月前
已完结
皖公网安备34019202002308
